About Allogenetics
Allogenetics provides a unique solution to the problem of organ rejection following transplantation.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Seed
Global Headquarters
Hanover, Germany
Tracked Since
Oct 2, 2026
Web & Domain Identity
Official Website
allogenetics.de
Domain Registered Date
Dec 7, 2022
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $4,427,760 · Seed
biospace.com
- Milestone
Website domain registered
allogenetics.de
Investors & Backers
Carma Fund
Life Science Valley Wachstumsfond
NBank Capital
Funding History
Seed
· Sep 9, 2026
$4,427,760 biospace.com
Founders & Leadership
Constanca Figueiredo
Founder
Work email & phone locked
Unlock →
Jeroen Rovers
Chief Medical Officer
Work email & phone locked
Unlock →
Oliver Ernst
CEO and Managing Director
Work email & phone locked
Unlock →
Phillipp Langrehr
Founder
Work email & phone locked
Unlock →
Rainer Blasczyk
Founder
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026